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Motivation: Gene expression measurements (microarray of RNA-seq) are affordable ways to survey cell activity. However, 
they constitute low-informative, decontextualized values that often lack a mechanistic link with real cell functional outcomes. 
Mathematical modeling of biological pathways is emerging as a useful tool to understand the molecular mechanisms that 
govern the cell behavior or fate, revealing disease mechanisms and drug mechanisms of action, and providing guidance on 
therapeutic decisions (Gustafsson et al., 2014).  
Methods: Signaling KEGG pathways are used as basic maps of cell functionality over which gene expression values are 
modeled to obtain probabilities of signal transduction and, consequently, cell function activations (Hidalgo et al, 2017). 
Results: Here we propose a new method that models cell signaling using biological knowledge on signal transduction (Hidalgo 
et al., 2017). The method recodes individual gene expression values (and/or gene mutations) into accurate measurements of 
changes in the activity of signaling circuits, which ultimately constitute high-throughput estimations of cell functionalities 
caused by gene activity within the pathway. Signaling circuit activities can predict cancer outcome and have also demonstrated 
to be excellent predictors of drug response (Amadoz et al., 2015) 
Conclusions: A comprehensive, systems-based understanding of the way in which genes interact to shape the phenotype is 
required to realistically manage complex diseases. 
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